ハイテンポな音楽で頭の回転も速くなるか

申請代表者： 人間科学部 1 年 具 滋閔共同研究者： 人間科学部 1 年 佐藤 那由多アドバイザー教員： 人間科学研究科 入戸野 宏採択番号: 人-0

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

Life-threatening `breakthrough' cases of critical COVID-19 are attributed to poor or waning antibody response to the SARS- CoV-2 vaccine in individuals already at risk. Pre-existing autoantibodies (auto-Abs) neutralizing type I IFNs underlie at least 15% of critical COVID-19 pneumonia cases in unvaccinated individuals; however, their contribution to hypoxemic breakthrough cases in vaccinated people remains unknown. Here, we studied a cohort of 48 individuals ( age 20-86 years) who received 2 doses of an mRNA vaccine and developed a breakthrough infection with hypoxemic COVID-19 pneumonia 2 weeks to 4 months later. Antibody levels to the vaccine, neutralization of the virus, and auto- Abs to type I IFNs were measured in the plasma. Forty-two individuals had no known deficiency of B cell immunity and a normal antibody response to the vaccine. Among them, ten (24%) had auto-Abs neutralizing type I IFNs (aged 43-86 years). Eight of these ten patients had auto-Abs neutralizing both IFN-a2 and IFN-., while two neutralized IFN-omega only. No patient neutralized IFN-ss. Seven neutralized 10 ng/mL of type I IFNs, and three 100 pg/mL only. Seven patients neutralized SARS-CoV-2 D614G and the Delta variant (B.1.617.2) efficiently, while one patient neutralized Delta slightly less efficiently. Two of the three patients neutralizing only 100 pg/mL of type I IFNs neutralized both D61G and Delta less efficiently. Despite two mRNA vaccine inoculations and the presence of circulating antibodies capable of neutralizing SARS-CoV-2, auto-Abs neutralizing type I IFNs may underlie a significant proportion of hypoxemic COVID-19 pneumonia cases, highlighting the importance of this particularly vulnerable population

N-Alkylthienopyrroledione versus benzothiadiazole pulling units in push–pull copolymers used for photovoltaic applications: density functional theory study

International audienceLow-band-gap push-pull copolymers are promising donor materials for bulk heterojunction organic solar cells. One of the best push-pull copolymers are composed of bridged dithiophene pushing units and benzothiadiazole (BT) pulling units, but BT has no proper position to accommodate alkyl side chains introduced to enhance the solubility of the resulting copolymers in organic solvents. On the other hand, N-alkylthienopyrroledione (TPD), which has an alkyl side chain attached to its pyrrole moiety, has been combined with various bridged dithiophene pushing units to give high-solubility donor polymers whose power conversion efficiencies are higher than those of the BT-based polymers especially after a morphology control. However, our well-validated time-dependent density functional theory calculation on the intrinsic (single-chain) electronic structure, which has been proved powerful to estimate the efficiency, gives a contradictory prediction that both polymers would show essentially the same efficiency. Intrigued by this, we subsequently perform density functional theory calculations on their π-stacked-pair models in a number of stacking configurations and conclude that the enhanced performance of the TPD-based polymers is ascribed to their enhanced inter-chain interaction resulting from their enhanced dipole moments in the push-pull direction. Enhanced morphological ordering (π-stacking and π-conjugation) in their solid films, which is not considered in electronic-structure calculations, would reduce the band gap (as proved by the low-energy shoulders in UV/vis absorption spectra), improve the charge transfer (as shown by the calculated transfer integral, transfer rate, and hole mobility), and enhance the power conversion efficiencies (as observed after a morphology control).-

Enhanced Specificity in Loop-Mediated Isothermal Amplification with Poly(ethylene glycol)-Engrafted Graphene Oxide for Detection of Viral Genes

Loop-mediated isothermal amplification (LAMP) is a nucleic acid amplification method that allows the simple, quick, and low-cost detection of various viral genes. LAMP assays are susceptible to generating non-specific amplicons, as high concentrations of DNA primers can give rise to primer dimerization and mismatched hybridizations, resulting in false-positive signals. Herein, we reported that poly(ethylene glycol)-engrafted nanosized graphene oxide (PEG-nGO) can significantly enhance the specificity of LAMP, owing to its ability to adsorb single-stranded DNA (ssDNA). By adsorbing surplus ssDNA primers, PEG-nGO minimizes the non-specific annealing of ssDNAs, including erroneous priming and primer dimerization, leading to the enhanced specificity of LAMP. The detection of complementary DNAs transcribed from the hepatitis C virus (HCV) RNA was performed by the PEG-nGO-based LAMP. We observed that the inclusion of PEG-nGO significantly enhances the specificity and sensitivity of the LAMP assay through the augmented difference in fluorescence signals between the target and non-target samples. The PEG-nGO-based LAMP assay greatly facilitates the detection of HCV-positive clinical samples, with superior precision to the conventional quantitative real-time PCR (RT-qPCR). Among the 20 clinical samples tested, all 10 HCV-positive samples are detected as positive in the PEG-nGO-based LAMP, while only 7 samples are detected as HCV-positive in the RT-qPCR. In addition, the PEG-nGO-based LAMP method significantly improves the detection precision for the false-positive decision by 1.75-fold as compared to the LAMP without PEG-nGO. Thus, PEG-nGO can significantly improve the performance of LAMP assays by facilitating the specific amplification of target DNA with a decrease in background signal

Palladium-Assisted Reaction of 2,2-Dialkylbenzimidazole and Its Implication on Organic Solar Cell Performances

International audienceA 2,2-dimethyl-2H-benzimidazole (22MBI) pulling unit has been synthesized as a potential high-solubility substitute for benzothiadiazole and incorporated into a push–pull-type copolymer used for decent-efficiency (∼3%) organic photovoltaic devices. We herein replace the two methyl side groups of 22MBI by longer alkyl (ethyl, butyl, and hexyl) side chains to further improve the solubility. However, the copolymers replaced by the new pulling units, 2,2-diethyl/dibutyl/dihexl-2H-benzimidazole (22EBI/22BBI/22HBI), lose favorable optical characteristics and exhibit negligible (29 kcal/mol) but could be reduced down to 8 kcal/mol in the presence of palladium-based polymerization catalysts. Indeed, the presence of the predicted 12BI-containing side products is confirmed by NMR spectra. A temperature-dependent polymerization experiment shows that 22MBI is in fact subject to the same type of isomerization when the temperature is raised to 150 °C above the original polymerization temperature (90–110 °C), further supporting the hypothesis from our calculations and explaining the observed anomalous side-group effect